Clustering data with hclust algorithm for Metabolomics analysis of Sirt5 knockdown (KD) melanoma (Study ST000698)

Reversed phase NEGATIVE ION MODE (Analysis AN001083)
MetaboliteStructureF1F2F3F4
GUANOSINE 5^-PHOSPHATE (CAS# 85-32-5); (M-H)-ME1983942.251.13NA0.73
HEPTADECANOATE (CAS# 506-12-7); (M-H)-ME1983951.041.03NA0.93
ARACHIDIC ACID (CAS# 506-30-9); (M-H)-ME1983231.041.10NA0.85
DEOXYCYTIDINE (CAS# 951-77-9); (M+HCOO)-ME1983561.470.84NA0.67
GUANOSINE (CAS# 118-00-3); (M+CL)-ME1983910.820.97NA1.47
4-NITROPHENOL (CAS# 100-02-7); (M-H)-ME1983020.751.09NA1.16
DEHYDROASCORBATE (CAS# 490-83-5); (M+HCOO)-ME1983541.520.84NA0.38
D-GLUCOSAMINE (CAS# 3416-24-8); (M+CL)-ME1983460.461.84NA0.39
GLUTATHIONE (CAS# 27025-41-8); (M-H)-ME1983881.031.06NA0.90
FRUCTOSE (CAS# 57-48-7); (M+HCOO)-ME1983691.001.05NA0.94
GLYCERALDEHYDE (CAS# 367-47-5); (2M-H)-[-H2O]ME1983891.141.15NA0.62
16:0 LYSO PC (CAS# 17364-16-8); (M+CL)-ME1982800.941.08NA0.98
5^-METHYLTHIOADENOSINE (CAS# 2457-80-9); (M+CL)-ME1983031.201.01NA0.79
DGMP (CAS# 902-04-5); (M-H)-ME1983571.290.81NA0.93
ELAIDIC ACID (CAS# 112-79-8); (M-H)-ME1983611.091.05NA0.85
EPIBRASSINOLIDE [ISTD] (CAS# 78821-43-9); (M+CL)-ME1983620.831.05NA1.11
GIBBERELLIC ACID [ISTD] (CAS# 77-06-5); (M-H)-ME1983770.881.01NA1.11
ADENOSINE (CAS# 58-61-7); (M+HCOO)-ME1983121.570.84NA0.56
GUANOSINE (CAS# 118-00-3); (M-H)-ME1983921.161.05NA0.72
5^-METHYLTHIOADENOSINE (CAS# 2457-80-9); (M+HCOO)-ME1983041.320.90NA0.77
CYTIDINE (CAS# 65-46-3); (M-H)-ME1983421.160.84NA1.02
CIS-ACONITATE (CAS# 585-84-2); (M-H)-ME1983341.920.89NA0.46
D-LYXOSE (CAS# 1114-34-7); (M+HCOO)-ME1983490.551.11NA1.43
GLUTAMATE (CAS# 56-86-0); (M-H)-ME1983851.100.97NA0.92
FLAVIN ADENINE DINUCLEOTIDE (CAS# 146-14-5); (M-H)-ME1983661.350.91NA0.78
5-OXOPROLINE (CAS# 4042-36-8); (M-H)-ME198309NA1.98NA0.72
CHOLINE PHOSPHATE (CAS# 107-73-3); (M+HCOO)-ME1983322.040.50NA0.99
CREATINE (CAS# 57-00-1); (M-H)-ME1983400.980.93NA1.12
4-NITROCATECHOL (CAS# 3316-09-4); (M-H)-ME1983010.761.12NA1.12
FRUCTOSE (CAS# 57-48-7); (M+CL)-ME1983680.961.21NA0.83
D-LYXOSE (CAS# 1114-34-7); (M-H)-ME1983501.061.05NA0.86
HIPPURATE (CAS# 495-69-2); (M-H)-ME1983960.951.39NA0.66
DOCOSAHEXAENOIC ACID (CAS# 6217-54-5 ); (M-H)-ME1983601.500.98NA0.59
CITRATE (CAS# 77-92-9); (M-H)-ME1983381.300.94NA0.76
16:0-18:0 PC (CAS# 59403-51-9); (M+HCOO)-ME1982820.880.99NA1.12
5-AMINOLEVULINATE (CAS# 106-60-5); (M-H)-ME1983051.150.93NA0.73
AZELAIC ACID (CAS# 123-99-9); (M-H)-ME1983260.680.81NA1.51
GLUTAMINE (CAS# 56-85-9); (M-H)-ME1983860.622.02NA0.43
3-HYDROXYBENZALDEHYDE (CAS# 100-83-4); (M-H)-ME1982910.881.16NA0.96
4-METHYL-2-OXOVALERIC ACID (CAS# 816-66-0); (M-H)-ME1982991.181.18NA0.64
DEHYDROASCORBATE (CAS# 490-83-5); (M-H)-ME1983551.050.84NA1.08
5-HYDROXYINDOLEACETATE (CAS# 54-16-0); (M-H)-ME1983071.560.58NANA
BENZOATE (CAS# 65-85-0); (M-H)-ME1983270.871.14NA0.99
GLUCOSE (CAS# 50-99-7); (M+CL)-ME1983810.961.21NA0.83
D-TAGATOSE (CAS# 87-81-0); (M+CL)-ME1983520.961.21NA0.83
3-(4-HYDROXYPHENYL)LACTATE (CAS# 6482-98-0); (M-H)-ME1982891.420.71NA0.77
D-GLUCOSE 6-PHOSPHATE (CAS# 56-73-5); (M-H)-ME1983471.110.93NA0.96
DIHYDROXYMANDELIC ACID (CAS# 775-01-9); (M-H)-ME1983590.850.92NA1.19
GUANOSINE 5^-DIPHOSPHO-BETA-L-FUCOSE (CAS# 0); (M-H)-ME1983931.370.87NA0.84
20:0 LYSO PC (CAS# 108341-80-6); (M+HCOO)-ME1982880.960.99NA1.06
CIS-VACCENIC ACID (CAS# 506-17-2); (M-H)-ME1983351.091.05NA0.85
2-METHYLGLUTARIC ACID (CAS# 18069-17-5); (M-H)-ME1982860.540.88NA1.41
16:0 LYSO PC (CAS# 17364-16-8); (M+HCOO)-ME1982810.901.07NA1.03
ADIPIC ACID (CAS# 124-04-9 ); (M-H)-ME1983140.540.84NA1.47
ARACHIDONATE (CAS# 506-32-1); (M-H)-ME1983241.131.02NA0.85
4-METHYL-2-OXOPENTANOATE (CAS# 816-66-0); (M-H)-ME1982981.171.17NA0.66
ADPGLUCOSE (CAS# ); (M-H)-ME1983161.360.87NA0.84
ALPHA-D-GALACTOSE 1-PHOSPHATE (CAS# 2255-14-3); (M-H)-ME1983191.110.93NA0.96
BETA-MALTOSE (CAS# 69-79-4); (M+HCOO)-ME1983300.720.94NA1.28
GLUCOSE (CAS# 50-99-7); (2M+CL)-[-H2O]ME1983800.701.24NA0.95
ADENINE (CAS# 73-24-5); (M-H)-ME1983111.080.93NA1.02
ALLOSE (CAS# 2595-97-3); (M-H)+[-H2O]ME1983181.241.11NA0.65
ASPARTATE (CAS# 56-84-8); (M-H)-ME1983251.020.93NA1.04
CYCLOHEPTANECARBOXYLIC ACID (CAS# 1460-16-8); (M+HCOO)-ME1983410.680.81NA1.51
BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O]ME1983281.310.07NANA
GLUCARIC ACID (CAS# 87-73-0); (M-H)+[-H2O]ME1983781.380.83NA0.79
L-[15N]ANTHRANILIC ACID [ISTD] (CAS# ); (M-H)-ME1984100.811.12NA1.07
2-HYDROXY-3-METHYLBUTYRIC ACID (CAS# 4026-18-0); (M-H)-ME1982851.111.03NA0.90
2-OXOADIPATE (CAS# 3184-35-8); (M-H)-ME1982871.081.29NA0.55
GAMMA-BUTYROLACTONE (CAS# 96-48-0); (M+HCOO)-ME1983720.961.23NA0.79
GLUTARATE (CAS# 110-94-1); (M-H)-ME1983870.961.23NA0.79
DIACETYL (CAS# 431-03-8); (M+HCOO)-ME1983580.961.23NA0.79
3-PHOSPHOGLYCERATE (CAS# ); (M-H)-ME1982941.270.67NA1.06
ADENOSINE 5^-MONOPHOSPHATE (CAS# 61-19-8); (M-H)-ME1983131.190.97NA0.83
3-METHYLADIPIC ACID (CAS# 3058-01-3); (M-H)-ME1982930.450.63NA1.83
GALACTURONIC ACID (CAS# 91510-62-2); (M-H)-ME1983711.030.84NA1.08
GLUCONIC ACID (CAS# 526-95-4); (M-H)-ME1983790.561.10NA1.43
4-NITROBENZOIC ACID (CAS# 62-23-7); (M-H)-ME1983000.801.12NA1.01
ALLANTOIN (CAS# 97-59-6); (M-H)-ME1983170.901.23NA0.88
ADP-RIBOSE (CAS# ); (M-H)-ME1983150.891.11NA1.01
LACTOSE (CAS# 63-42-3); (M+CL)-ME1984110.961.08NA0.92
BETA-MALTOSE (CAS# 69-79-4); (M+CL)-ME1983290.961.08NA0.92
DECANOATE (CAS# 334-48-5); (M-H)-ME1983530.591.25NA1.23
EPIBRASSINOLIDE [ISTD] (CAS# 78821-43-9); (M+HCOO)-ME1983630.821.08NA1.10
CIS-ZEATIN (CAS# 1637-39-4); (M+CL)-ME1983360.881.15NA0.97
INOSINE (CAS# 58-63-9); (M-H)-ME1984001.161.05NA0.77
ARABITOL (CAS# 7643-75-6); (M+CL)-ME1983221.49NANA0.75
CIS-11-EICOSENOIC ACID (CAS# 5561-99-9); (M-H)-ME1983331.081.01NA0.90
D-LYXOSE (CAS# 1114-34-7); (M+CL)-ME1983480.881.09NA1.05
4-HYDROXY-L-PROLINE (CAS# 2584-71-6); (M-H)-ME1982961.190.92NA0.83
ALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-ME1983201.051.04NA0.89
ISOLEUCINE (CAS# 73-32-5); (M-H)-ME1984031.201.10NA0.75
ISOCITRATE (CAS# 320-77-4); (M-H)-ME1984021.300.88NA0.82
5-AMINOPENTANOATE (CAS# 660-88-8); (M-H)-ME1983061.090.99NA0.92
INOSINE 5^-PHOSPHATE (CAS# 131-99-7); (M-H)-ME1984011.350.90NA0.91
D-(-)-ARABINOSE (CAS# 10323-20-3); (M+HCOO)-ME1983440.561.10NA1.43
GLUCURONIC ACID (CAS# 6556-12-3); (M-H)-ME1983841.030.84NA1.08
GIBBERELLIC ACID [ISTD] (CAS# 77-06-5); (2M-H)-ME1983750.811.07NA1.12
GIBBERELLIC ACID [ISTD] (CAS# 77-06-5); (M+CL)-ME1983760.851.06NA1.10
D-GALACTOSAMINE (CAS# 7535-00-4); (M+CL)-ME1983450.461.84NA0.39
D-PSICOSE (CAS# 551-68-8); (M+CL)-ME1983510.961.22NA0.83
GLYCEROL 2-PHOSPHATE (CAS# ); (M-H)-ME1983900.980.99NA1.03
2-AMINOETHYL DIHYDROGEN PHOSPHATE (CAS# 1071-23-4 ); (M-H)-ME1982840.390.93NA1.47
CITRULLINE (CAS# 372-75-8); (M-H)-ME1983391.240.99NA0.92
6-CARBOXYHEXANOATE (CAS# 111-16-0); (M-H)-ME1983100.450.63NA1.83
CYTIDINE 5^-DIPHOSPHOCHOLINE (CAS# 987-78-0); (M+CL)-ME1983431.020.92NA1.07
CIS-ZEATIN (CAS# 1637-39-4); (M-H)-ME1983370.921.10NA0.98
ETHYLMALONIC ACID (CAS# 601-75-2); (M-H)-ME1983650.301.17NANA
18:0 LYSO-PE (CAS# 69747-55-3); (M-H)-ME1982831.121.03NA0.85
FOLIC ACID (CAS# 59-30-3); (M-H)-ME1983670.921.27NA0.80
GLUCOSE 1-PHOSPHATE (CAS# 59-56-3); (M-H)-ME1983821.110.93NA0.96
GLUCURONIC ACID (CAS# 6556-12-3); (M+CL)-ME1983831.000.95NA1.11
4-HYDROXYBENZALDEHYDE (CAS# 123-08-0); (M-H)-ME1982970.871.14NA0.99
ETHANOLAMINE PHOSPHATE (CAS# 1071-23-4); (M-H)-ME1983640.390.93NA1.46
HYODEOXYCHOLATE (CAS# 83-49-8); (M-H)-ME1983990.961.11NA0.94
FUMARATE (CAS# 110-17-8); (M-H)-ME1983701.051.09NA0.79
GDPMANNOSE (CAS# ); (M-H)-ME1983741.170.98NA0.85
3-HYDROXY-3-METHYLGLUTARATE (CAS# 503-49-1); (M-H)-ME1982901.191.15NA0.66
5-HYDROXYTRYPTOPHAN (CAS# 4350-09-8); (M-H)-ME1983081.140.48NA1.77
CELLOBIOSE (CAS# 528-50-7); (M+CL)-ME1983310.961.08NA0.92
3-METHYGLUTARIC ACID (CAS# 626-51-7); (M-H)-ME1982920.540.84NA1.47
4-ACETAMIDOBUTANOATE (CAS# 3025-96-5); (M-H)-ME1982951.200.95NA1.01

Factors:

F1Condition:no | KD#1:no | KD#2:yes
F2Condition:no | KD#1:yes | KD#2:no
F3Condition:Pooled melanoma | KD#1:Pooled melanoma | KD#2:Pooled melanoma
F4Condition:yes | KD#1:no | KD#2:no
Data matrix
  logo